Brevilin a Induces ROS-dependent Apoptosis and Suppresses STAT3 Activation by Direct Binding in Human Lung Cancer Cells

Journal of Cancer - Australia
doi 10.7150/jca.40983
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Ivyspring International Publisher

Related search

Sophoridine Induces Apoptosis and S Phase Arrest via ROS-dependent JNK and ERK Activation in Human Pancreatic Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2017English

Alisol B 23-Acetate Induces Autophagic-Dependent Apoptosis in Human Colon Cancer Cells via ROS Generation and JNK Activation

Oncotarget
Oncology
2017English

Quinalizarin Induces ROS‑mediated Apoptosis via the MAPK, STAT3 and NF‑κB Signaling Pathways in Human Breast Cancer Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

YC-1 Suppresses Constitutive Nuclear Factor- B Activation and Induces Apoptosis in Human Prostate Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2005English

Type III Interferon Induces Apoptosis in Human Lung Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2012English

Ceramide Induces Mitochondrial Activation and Apoptosis via a Bax-Dependent Pathway in Human Carcinoma Cells

Oncogene
Cancer ResearchGeneticsMolecular Biology
2002English

Cordycepin Induces Apoptosis in Human Bladder Cancer T24 Cells Through ROS-dependent Inhibition of the PI3K/Akt Signaling Pathway

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2019English

Development of Erasin: A Chromone-Based STAT3 Inhibitor Which Induces Apoptosis in Erlotinib-Resistant Lung Cancer Cells

Scientific Reports
Multidisciplinary
2017English

Oleanane Triterpenoid CDDO-Me Inhibits Growth and Induces Apoptosis in Prostate Cancer Cells Through a ROS-dependent Mechanism

Biochemical Pharmacology
BiochemistryPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy